Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 2
2011 1
2013 2
2014 1
2015 2
2016 1
2018 2
2019 1
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma.
Calderaro J, Meunier L, Nguyen CT, Boubaya M, Caruso S, Luciani A, Amaddeo G, Regnault H, Nault JC, Cohen J, Oberti F, Michalak S, Bouattour M, Vilgrain V, Pageaux GP, Ramos J, Barget N, Guiu B, Paradis V, Aubé C, Laurent A, Pawlotsky JM, Ganne-Carrié N, Zucman-Rossi J, Seror O, Ziol M. Calderaro J, et al. Clin Cancer Res. 2019 Oct 1;25(19):5859-5865. doi: 10.1158/1078-0432.CCR-19-0859. Epub 2019 Jul 29. Clin Cancer Res. 2019. PMID: 31358545
Two candidate biomarkers, Endothelial-Specific Molecule 1 (ESM1) and Carbonic Anhydrase IX (CAIX), were selected. In the discovery series, sensitivity and specificity of ESM1 expression by stromal endothelial cells for the detection of MTM-HCC were 97% (28/29 …
Two candidate biomarkers, Endothelial-Specific Molecule 1 (ESM1) and Carbonic Anhydrase IX (CAIX), were selected. In the discovery se …
ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.
Kang YH, Ji NY, Lee CI, Lee HG, Kim JW, Yeom YI, Kim DG, Yoon SK, Kim JW, Park PJ, Song EY. Kang YH, et al. Amino Acids. 2011 Mar;40(3):1003-13. doi: 10.1007/s00726-010-0729-6. Epub 2010 Sep 7. Amino Acids. 2011. PMID: 20821239
RT-PCR and Western Blot analysis revealed overexpression of ESM-1 in human HCC liver tissue and in serum from patients with HCC. ...Based on our results, we suggest that ESM-1 or a combination of ESM-1 and AFP is useful mark …
RT-PCR and Western Blot analysis revealed overexpression of ESM-1 in human HCC liver tissue and in serum from patients …
EpCAM, Ki67, and ESM1 Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation.
Hemida AS, Taie DM, El-Wahed MMA, Shabaan MI, Tantawy MS, Ehsan NA. Hemida AS, et al. Appl Immunohistochem Mol Morphol. 2023 Oct 1;31(9):596-606. doi: 10.1097/PAI.0000000000001150. Epub 2023 Sep 4. Appl Immunohistochem Mol Morphol. 2023. PMID: 37668411
Little is known regarding use of tissue expression of epithelial cell adhesion molecule (EpCAM) to predict HCC recurrence. This study investigates the role of EpCAM, Ki67, and endothelial-cell-specific molecule-1 (ESM1) as immunohistochemical markers to predict H
Little is known regarding use of tissue expression of epithelial cell adhesion molecule (EpCAM) to predict HCC recurrence. This study …
Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma.
Wahb AMSE, El Kassas M, Khamis AK, Elhelbawy M, Elhelbawy N, Habieb MSE. Wahb AMSE, et al. World J Hepatol. 2021 Nov 27;13(11):1753-1765. doi: 10.4254/wjh.v13.i11.1753. World J Hepatol. 2021. PMID: 34904043 Free PMC article.
AIM: To analyze the levels of miRNA 9-3p and endocan in HCV-infected HCC patients and correlate them with clinicopathological parameters. ...Moreover miRNA 9-3p and endocan performed better than alpha-fetoprotein in discriminating HCC patients from cir …
AIM: To analyze the levels of miRNA 9-3p and endocan in HCV-infected HCC patients and correlate them with clinicopathological …
Serum human endothelial cell-specific molecule-1 (endocan) and vascular endothelial growth factor in cirrhotic HCV patients with hepatocellular carcinoma as predictors of mortality.
Youssef AA, Issa HA, Omar MZ, Behiry EG, Elfallah AA, Hasaneen A, Darwish M, Ibrahim DB. Youssef AA, et al. Clin Exp Gastroenterol. 2018 Nov 23;11:431-438. doi: 10.2147/CEG.S171339. eCollection 2018. Clin Exp Gastroenterol. 2018. PMID: 30538523 Free PMC article.
The serum VEGF and endocan were assessed by ELISA. RESULTS: The mean serum endocan level was 4257.6 847.6 pg/mL in HCC patients, compared to 2099.2 459.6 pg/mL in liver cirrhosis patients without HCC. ...Endocan at cut-off value 2967 pg/ml had h …
The serum VEGF and endocan were assessed by ELISA. RESULTS: The mean serum endocan level was 4257.6 847.6 pg/mL in HCC
[Expression of ESM-1 in hepatocellular carcinoma is associated with angiogenesis and tumor invasion].
Xiang X, Zhao WB, Wang X. Xiang X, et al. Zhonghua Gan Zang Bing Za Zhi. 2009 Sep;17(9):661-4. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19785952 Chinese.
OBJECTIVE: To study the expression and significance of endothelial cell specific molecule-1 (ESM-1) in hepatocellular carcinoma (HCC) tissue and serum from HCC patients. ...CONCLUSION: The expression of ESM-1 is significantly up-regulated …
OBJECTIVE: To study the expression and significance of endothelial cell specific molecule-1 (ESM-1) in hepatocellular carcinom …
Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer.
Xiao Y, Zhang G, Wang L, Liang M. Xiao Y, et al. Front Endocrinol (Lausanne). 2022 Nov 28;13:1069528. doi: 10.3389/fendo.2022.1069528. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36518242 Free PMC article.
A prognostic nomogram based on the four-gene signature exhibited a best predictive performance, which enabled the prognosis prediction of CRC patients. The hub gene ESM1 related to CRC were selected via the machine learning and prognostic analysis. RT-PCR, Western blot and …
A prognostic nomogram based on the four-gene signature exhibited a best predictive performance, which enabled the prognosis prediction of CR …
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
Ziol M, Sutton A, Calderaro J, Barget N, Aout M, Leroy V, Blanc JF, Sturm N, Bioulac-Sage P, Nahon P, Nault JC, Charnaux N, N'kontchou G, Trinchet JC, Delehedde M, Seror O, Beaugrand M, Vicaut E, Ganne-Carrié N. Ziol M, et al. J Hepatol. 2013 Dec;59(6):1264-70. doi: 10.1016/j.jhep.2013.07.030. Epub 2013 Aug 6. J Hepatol. 2013. PMID: 23928407
The 2 independent predictive factors of overall recurrence were serum AFP (HR 1.11 [1.002; 1.22], p=0.045) and ESM-1 expression (HR 1.56 [1.004; 2.43], p=0.048). ESM-1 expression was also an independent predictive factor of early recurrence (HR 1.81 [1 …
The 2 independent predictive factors of overall recurrence were serum AFP (HR 1.11 [1.002; 1.22], p=0.045) and ESM-1 expressio …
Is serum endocan a sensitive biomarker for early recurrence of hepatocellular carcinoma after radiofrequency ablation?
Omar SA, Attia NM, Sheir MI, Amer AS, El Shabrawy MM, Hasan BB. Omar SA, et al. Eur J Gastroenterol Hepatol. 2021 Jul 1;33(7):1015-1022. doi: 10.1097/MEG.0000000000002074. Eur J Gastroenterol Hepatol. 2021. PMID: 33867440
More recent studies on HCC showed that the elevated serum endocan level was a predictive factor of recurrence after radiofrequency ablation. ...The serum endocan level had a positive correlation with recurrence of HCC (P < 0.0001). ...
More recent studies on HCC showed that the elevated serum endocan level was a predictive factor of recurrence after radiofrequ …
Phenotypic and molecular changes in nodule-in-nodule hepatocellular carcinoma with pathogenetic implications.
Rudini N, Novello C, Destro A, Riboldi E, Donadon M, Viganò L, Morenghi E, Roncalli M, Di Tommaso L. Rudini N, et al. Histopathology. 2018 Oct;73(4):601-611. doi: 10.1111/his.13659. Epub 2018 Jul 20. Histopathology. 2018. PMID: 29791027
AIMS: Nodule-in-nodule (N/N) hepatocellular carcinoma (HCC) is a convincing proof of multistep hepatocarcinogenesis. In this lesion, an inner HCC develops within an outer, more differentiated, tumour, which can be rapidly taken over by the former so that N/N HCC
AIMS: Nodule-in-nodule (N/N) hepatocellular carcinoma (HCC) is a convincing proof of multistep hepatocarcinogenesis. In this lesion, …
16 results